REPL — Replimune Group, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-07-20.
Performance
Technicals
Others in Healthcare
Measured signals that fired on REPL
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-08-03 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-03 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-08-03 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-31 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-27 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-17 | Hill Emily Luisa Chief Financial Officer | Open-market sale | 9.3K | 14.28 | 132.2K |
| 2026-08-10 | Patel Sushil Chief Executive Officer | Open-market sale | 39.3K | 12.97 | 510.3K |
| 2026-08-10 | Hill Emily Luisa Chief Financial Officer | Open-market sale | 11.4K | 12.97 | 148.5K |
| 2026-08-10 | Xynos Konstantinos Chief Medical Officer | Open-market sale | 11.4K | 12.97 | 148.5K |
| 2026-08-10 | Schwendenman Andrew Chief Accounting Officer | Open-market sale | 7.6K | 12.97 | 99.0K |
| 2026-06-01 | Sarchi Christopher Chief Commercial Officer | Open-market sale 10b5-1 plan | 12.0K | 9.24 | 110.9K |
| 2026-05-18 | Patel Sushil Chief Executive Officer | Open-market sale | 37.3K | 5.08 | 189.6K |
| 2026-05-18 | Astley-Sparke Philip Director | Open-market sale | 17.7K | 5.08 | 89.7K |
| 2026-05-18 | Xynos Konstantinos Chief Medical Officer | Open-market sale | 14.0K | 5.08 | 71.2K |
| 2026-05-18 | Sarchi Christopher Chief Commercial Officer | Open-market sale | 8.6K | 5.08 | 43.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BAKER BROS. ADVISORS LP | 84.5M | 11.0M |
| RTW INVESTMENTS, LP | 56.3M | 7.4M |
| BlackRock, Inc. | 47.7M | 6.2M |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 32.3M | 4.2M |
| STATE STREET CORP | 28.9M | 3.8M |
| FCPM III SERVICES B.V. | 21.5M | 2.8M |
| VANGUARD CAPITAL MANAGEMENT LLC | 21.1M | 2.8M |
| D. E. Shaw & Co., Inc. | 17.9M | 2.3M |
| GOLDMAN SACHS GROUP INC | 17.4M | 2.3M |
| FMR LLC | 15.6M | 2.0M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| S-3ASR | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-12 | 2026-08-10 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Robbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action · 2026-08-21
- Replimune Group stock may move 5.6% on earnings release · 2026-08-14
- Replimune Group, Inc. (REPL) filed form 8-K · 2026-08-14 · SEC EDGAR
- Replimune Group, Inc. (REPL) filed form S-3ASR · 2026-08-14 · SEC EDGAR
- Replimune Group, Inc. (REPL) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Replimune Group, Inc. (REPL) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
Ask the AI about REPL
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →